| Low dose posaconazole delayed release tablets for fungal prophylaxis in lung transplant recipients JM Kozuch, A Feist, G Yung, L Awdishu, S Hays, JP Singer, R Florez Clinical Transplantation 32 (8), e13300, 2018 | 11 | 2018 |
| A pilot trial for prevention of hepatitis C virus transmission from donor to organ transplant recipient with short-course glecaprevir/pibrentasvir C Ramirez-Sanchez, J Kozuch, MM Shah, J Berumen, K Mekeel, ... Open forum infectious diseases 9 (11), ofac550, 2022 | 4 | 2022 |
| Use of patisiran following heart transplant in a patient with hereditary transthyretin cardiac amyloidosis and polyneuropathy MA Urey, AL Topik, JL Saulog, K Leas, T Boarman, JM Kozuch, ... The Journal of Heart and Lung Transplantation 40 (4), S477-S478, 2021 | 1 | 2021 |
| Posaconazole Delayed Release Tablets for Antifungal Prophylaxis in Lung Transplant Patients JM Kozuch, AA Feist, G Yung, L Awdishu, RF Boettger, SR Hays The Journal of Heart and Lung Transplantation 34 (4), S241, 2015 | 1 | 2015 |
| Improved kidney function and one-year survival with transitioning from intravenous to enteral tacrolimus in lung transplant recipients C Burt, G Waldman, L Awdishu, K Afshar, M Mariski, J Kozuch, G Yung, ... Transplantation Reports 9 (2), 100150, 2024 | | 2024 |
| Prophylaxis of Donor-Derived HCV Infection in Cardiothoracic Transplant Recipients with Short-Course DAA Therapy JM Kozuch, S Aslam The Journal of Heart and Lung Transplantation 43 (4), S57, 2024 | | 2024 |
| Using HCV‐viremic organs for lung transplantation does not confer higher rejection rates compared to HCV‐negative organs K Afshar, E Schonhoft, J Kozuch, A Kafi, G Yung, T Pollema, E Golts, ... Clinical Transplantation 38 (2), e15260, 2024 | | 2024 |
| Difference in immunosuppressant dose requirement when transitioning to isavuconazole from other azoles in thoracic transplant recipients JM Kozuch, C Burt, K Afshar, S Aslam, G Yung, M Mariski, E Golts, A Feist Transplant Infectious Disease 26 (1), e14209, 2024 | | 2024 |
| HCV-Viremic Lung Transplantation Does Not Confer Higher Rejection Rates Compared to HCV-Negative Transplant K Afshar, E Schonhoft, J Kozuch, A Kafi, G Yung, T Pollema, E Golts, ... The Journal of Heart and Lung Transplantation 41 (4), S530, 2022 | | 2022 |
| Risk Factors for Invasive Fungal Infections in Heart Transplant Recipients L Frankul, C Ramirez-Sanchez, R Sigler, J Kozuch, N Law, H Tran, ... The Journal of Heart and Lung Transplantation 41 (4), S180, 2022 | | 2022 |
| Successful Single-Center Experience Using HCV plus Organs for Single and Dual-Organ Transplantation S Aslam, C Logan, N Law, J Kerr, J Kozuch, V Ajmera, K Afshar, A Khan, ... AMERICAN JOURNAL OF TRANSPLANTATION 21, 642-642, 2021 | | 2021 |
| INDUCTION IN CARDIAC TRANSPLANTATION: THYMOGLOBULIN VERSUS BASILIXIMAB KN Hong, G Macias, N Rodman, J Kozuch, V Pretorius, E Adler Journal of the American College of Cardiology 77 (18_Supplement_1), 835-835, 2021 | | 2021 |
| Evaluation of Induction Strategies in Heart Transplant at a Single Center VN Nguyen, CA Burt, E Adler, VG Pretorius, M Mariski, JM Kozuch The Journal of Heart and Lung Transplantation 39 (4), S278, 2020 | | 2020 |
| Improved Kidney Function Post Lung Transplant with Intravenous Tacrolimus Avoidance C Burt, A Feist, K Afshar, L Awdishu, M Mariski, J Kozuch, G Yung, E Golts AMERICAN JOURNAL OF TRANSPLANTATION 20, 1147-1147, 2020 | | 2020 |
| Development and Impact of DSA after Lung Transplant M Henderson, G Morris, C Burt, A Feist, J Kozuch, E Schonhoft, G Yung, ... AMERICAN JOURNAL OF TRANSPLANTATION 20, 1139-1139, 2020 | | 2020 |
| Isavuconazonium Pharmacokinetic Interactions with Immunosuppression in Thoracic Transplant Recipients C Burt, J Kozuch, M Mariski, A Feist, K Afshar, G Yung, T Floreth, E Golts, ... The Journal of Heart and Lung Transplantation 38 (4), S118, 2019 | | 2019 |
